The primary metabolic defect in subjects susceptible to hemolysis by various drugs and fava beans is considered to be the low glucose-6-phosphate dehydrogenase (G6PD) activity in their red cells (1, 2) . Such diminished enzymatic activity could be the end result of qualitative or quantitative changes in the enzyme as well as enzyme inhibition or lack of enzyme activation. However, studies on the properties of erythrocyte G6PD in such subjects and in normal subjects revealed no qualitative difference between them (3, 4).
The primary metabolic defect in subjects susceptible to hemolysis by various drugs and fava beans is considered to be the low glucose-6-phosphate dehydrogenase (G6PD) activity in their red cells (1, 2) . Such diminished enzymatic activity could be the end result of qualitative or quantitative changes in the enzyme as well as enzyme inhibition or lack of enzyme activation. However, studies on the properties of erythrocyte G6PD in such subjects and in normal subjects revealed no qualitative difference between them (3, 4) .
In a previous communication we demonstrated the presence of an activator of G6PD in normal erythrocyte stroma which increased the G6PD activity in the "sensitive" 1 hemolysate (5). This activator was found to be absent in the stroma of "sensitive" erythrocytes. Our recent finding that G6PD activity is also present in red cell stroma made it necessary to reinvestigate the validity of the G6PD activator.
METHODS
Bank blood collected in an ACD 2 solution and stored for about 2 weeks was used for the preparation of stroma. The red cells were washed three times in 0.85 per cent NaCl solution and the red cell stroma was prepared by gradual hemolysis as follows: to 1 vol of packed erythrocytes 9 vol of cold distilled water was added by drops, using a magnetic stirrer. The stroma was obtained by centrifugation at 28,000 G for 30 minutes. The stroma was suspended in 10 vol of 0.15 per cent NaCl solution and centrifuged for 5 minutes. This procedure was * This work was supported by grants from the Rockefeller Foundation and the United States Public Health Service (A-2740). 1 Hemolysates and stroma obtained from erythrocytes which exhibit a very low G6PD activity will be referred to as "sensitive."
2 Acid citrate dextrose, Formula B. National Institutes of Health, USA. repeated about ten times until the supernatant was almost colorless and contained no G6PD activity. The packed stroma was diluted with an equal volume of 0.85 per cent NaCl solution. One ml of such a stroma suspension contains about 30 mg dry weight. The hemolysates were prepared from fresh blood taken in heparin or ACD solution. The red cells were washed three times in 0.85 per cent NaCl solution. The cells were lysed by the addition of 4 vol of water to 1 vol of packed red cells. The stroma was removed from the hemolysates by centrifugation at 28,000 G and the supernatants used.
Glucose-6-phosphate dehydrogenase and 6-phosphogluconic dehydrogenase (6PGD) were assayed by a slight modification of the method of Kornberg and Horecker (6) and Horecker and Smyrniotis, respectively (7), as used in this laboratory (8) .
The presence of G6PD and 6PGD in stroma suspension was demonstrated by the method of Motulsky and Campbell (9), which is based on dye discoloration. The reaction mixture contained 0.4 ml stroma suspension added to 2 ml water. To that were added 0.4 ml of 0.25 M Tris buffer, pH 7.5; 0.5 ml of 5 X 10-M glucose-6-phosphate or 6-phosphogluconate; 0.1 mg TPN; and 0.5 ml of 0.03 per cent brilliant cresyl blue. After mixing, the reaction mixture was covered with 1 ml mineral oil and incubated at 370 C. The rate of the dye reduction is directly related to TPNH formation. The latter is formed when either the glucose-6-phosphate or 6-phosphogluconate is oxidized. This is a semiquantitative screening method used to distinguish normal from G6PD-deficient subjects.
Partial purification of G6PD was performed by precipitating the enzyme from a normal or "sensitive" hemolysate with 20 per cent ethanol. The precipitate was suspended in 0.2 M Tris buffer, pH 8 that normal red cell stroma has significantly increased the enzymatic activity of sensitive hemolysates (sometimes even to normal levels). No such effect was observed with sensitive stroma. When sensitive and normal stroma were mixed in different proportions the activating capacity of normal stroma was not affected.
The activation reaction progressed with time ( Figure 1 ). It can be seen that under these experimental conditions the activation reached its maximum at about 10 minutes. This reaction was found to be pH-dependent, being optimal at about pH 7.2 ( Figure 2 ), and temperature-dependent ( Figure 3 ).
The effect of metal ions was tested on the activation reaction and on G6PD activity. The incubation mixture consisted of 1 ml of "sensitive" hemolysate, 1 ml of stroma suspension and 2 ml buffer, at the desired pH, with 5 per cent succinic acid solution. The pH of the reaction mixture was tested and the obtained pH of the mixture is indicated in the figure. After incubation, the reaction mixture was centrifuged at 28,000 G for 10 minutes and the supernatants were used for the assay.
represents the effect of mercury on both reactions. As can be seen from the figure, the activation reaction was found to be more sensitive to Hg than the G6PD activity per se. Fifty per cent inhibition of these two activities was obtained by 5 The action of the activator on partially purified enzyme was also tested; 0.5 ml of stroma suspension was added to 0. (Table IV) .
The activator was found to be labile; it was destroyed when an acetone-dried powder was prepared from the stroma or by freezing and thawing the stroma. It was also completely destroyed by heating the stroma for 10 minutes at 80'C, and partially destroyed at lower temperatures (Figure 5 ).
G6PD activity in red cell stroma. During our preliminary work on the activating capacity of normal red cell stroma, no G6PD or 6PGD could be demonstrated in it. Normal red cell stroma was incubated with water, saline or Tris buffer, pH 7.4, for up to 2 hours and no enzymatic activity could be shown in the supernatant. However, when the stroma was tested by the method of Motulsky, G6PD and 6PGD activities were de- V. When the amount of stroma was doubled or tripled, the amount of enzyme released upon freezing also doubled or tripled. In Table IV we compare the activating capacity of 1 ml of stroma to its G6PD content. As can be seen from this table, the amount of enzyme released from normal stroma was found to be much smaller than the increase of G6PD activity in a sensitive hemolysate incubated with normal stroma. The same stroma on four consecutive activations increased the G6PD activity of sensitive hemolysate about 30 times more than the amount of enzyme that could have been released from this amount of stroma by freezing and thawing. Furthermore, when the same stroma was frozen and thawed, the amount of G6PD released was not much lower than the amount of enzyme that was present in the stroma before activation (Table IV) . In addition, G6PD could not be extracted from stroma suspended in 1 M or 2 M NaCl solution. These results prove that the increase of G6PD activity in sensitive he- molysates upon the addition of normal stroma was indeed an activation reaction and not an elution of enzyme from stroma.
As far as the bound G6PD and 6PGD are concerned, the question arose of whether these are the same enzyme as that in the hemolysate. The pH optimum and temperature lability were found to be the same for the bound and soluble G6PD. Since these data were obtained on crude preparations, no final conclusions can yet be drawn.
DISCUSSION
The main defect in the erythrocytes of individuals "sensitive" to primaquine and other drugs as well as to fava beans was considered to be the low glucose-6-phosphate dehydrogenase activity (1, 2) . This enzymatic defect was found in Negroes, non-Ashkenazic Jews, Sardinians, Sicilians, Chinese and others (10) (11) (12) . This defect is transmitted as a sex-linked incompletely dominant trait with variable expressivity in the heterozygous female (13, 14) . In "sensitive" Jews and Italians the enzymatic defect was found in other tissues also, while in Negroes the defect was found solely in the erythrocytes (8, (15) (16) (17) (18) .
Recently we observed that normal red cell stroma was capable of partial restoration of the enzymatic activity of sensitive hemolysates (5); this finding could suggest that the enzymatic deficiency in those individuals is of only secondary nature, while the primary defect is possibly in the stroma. This suggestion is strengthened by the fact that several authors were unable to show any qualitative difference between the G6PD of normal and sensitive erythrocytes (3, 4) .
Since we demonstrated that there are stromabound G6PD and 6PGD, the major problem was to exclude the possibility that the activation effect was not the result of elution of the enzymes from the stroma. The following results confirm our earlier observations (5).
a) The augmentation in the G6PD activity was observed only when normal stroma was incubated with a sensitive hemolysate. Normal stroma had no effect on a normal hemolysate; in fact, it frequently decreased its activity. b) G6PD could not be eluted from stroma incubated at 370 with water, saline, or Tris buffer. c) The activating capacity of stroma did not depend upon the amount of stroma. Small amounts of stroma activated as well as large amounts, the difference being only in the rate of the reaction (Table III) (19, 20) . However, from the data mentioned it is not yet possible to suggest a definite mechanism of the G6PD activation.
The possibility that sensitive stroma possessed an inhibitor of the G6PD activator was excluded, since sensitive stroma did not inhibit the activating capacity of normal red cell stroma on sensitive hemolysates.
The effect of heavy metal ions and p-CMB on this reaction suggests that sulfhydryl groups may be important in this reaction. Only after a highly purified G6PD is obtained, will it be possible to learn more about the specificity of the activator. Difficulties arose when we tried to purify the activator. Since it was a labile substance, it was destroyed by freezing and thawing of the stroma, by heating the stroma to 800 C, and when an acetone powder of stroma was prepared.
Our present hypothesis is that G6PD is synthesized in an inactive form in both normal and sensitive subjects. In the normal subject the enzyme is activated by an erythrocyte stroma factor. Since such an activator was found to be absent in sensitive red cells, lack of it may be responsible for the apparently low or deficient G6PD activity. In the normal erythrocytes the activator probably activated the G6PD to a maximal level in vivo, since the addition of normal stroma to normal hemolysate did not increase the enzymatic activity. This hypothesis will not change the genetic aspects of this abnormality, the only implication being that the primary genetic lesion affects the G6PD activator, rather than the enzyme per se. Using this hypothesis, heterozygous females with varying levels of this enzyme are being investigated. SUM MARY 1. A factor capable of activating glucose-6-phosphate dehydrogenase of "sensitive" erythrocytes was found in normal red cell stroma. This activation reaction was found to be dependent upon time, temperature and pH. The inhibitory affects of Ag+, Hg++, Cu++ and parachloromercuribenzoate were studied. The kinetics of the activation reaction suggest that it is enzymatic.
2. This activator was destroyed by freezing and thawing, heating, and cold acetone treatment.
3. Small amounts of tightly bound glucose-6-phosphate and 6-phosphogluconic dehydrogenase were detected in red cell stroma.
4. The data prove that the glucose-6-phosphate dehydrogenase activation is not the result of elution of the enzyme from normal red cell stroma.
